Osanami A, Kanda M, Sato T, Akazawa C, Baba S, Komatsu H
Front Endocrinol (Lausanne). 2022; 13:997296.
PMID: 36157458
PMC: 9500182.
DOI: 10.3389/fendo.2022.997296.
Ogawa W, Araki E, Ishigaki Y, Hirota Y, Maegawa H, Yamauchi T
Diabetol Int. 2022; 13(2):337-343.
PMID: 35463863
PMC: 8980125.
DOI: 10.1007/s13340-022-00570-5.
Hata K, Koyama T, Ozaki E, Kuriyama N, Mizuno S, Matsui D
Healthcare (Basel). 2021; 9(2).
PMID: 33546229
PMC: 7913305.
DOI: 10.3390/healthcare9020162.
Hirota Y, Suwanai H, Yamauchi T, Kadowaki T
J Diabetes Res. 2020; 2020:4359787.
PMID: 32337291
PMC: 7166280.
DOI: 10.1155/2020/4359787.
Takeuchi T, Ishigaki Y, Hirota Y, Hasegawa Y, Yorifuji T, Kadowaki H
J Diabetes Investig. 2019; 11(3):603-616.
PMID: 31677333
PMC: 7232299.
DOI: 10.1111/jdi.13171.
Lack of Association between Past Infection and Diabetes: A Two-Cohort Study.
Pyo J, Lee H, Choi S, Cho S, Choi Y, Min Y
Nutrients. 2019; 11(8).
PMID: 31409000
PMC: 6723734.
DOI: 10.3390/nu11081874.
Saibokuto as a Possible Therapy for Type B Insulin Resistance Syndrome: The Disappearance of Anti-insulin Receptor Antibody and a Marked Amelioration of Glycemic Control by Saibokuto Treatment.
Kawasaki F, Anno T, Takai M, Irie S, Kaneto H, Kaku K
Intern Med. 2018; 57(16):2359-2363.
PMID: 29526960
PMC: 6148171.
DOI: 10.2169/internalmedicine.0523-17.
H. pylori seroprevalence and risk of diabetes: An ancillary case-control study nested in the diabetes prevention program.
AlZahrani S, Nelson J, Moss S, Paulus J, Knowler W, Pittas A
J Diabetes Complications. 2017; 31(10):1515-1520.
PMID: 28739267
PMC: 5603174.
DOI: 10.1016/j.jdiacomp.2017.05.015.
Effect of eradication on insulin resistance among prediabetic patients: A pilot study and single-blind randomized controlled clinical trial.
Kachuei A, Amini M, Sebghatollahi V, Feizi A, Hamedani P, Iraj B
J Res Med Sci. 2016; 21:8.
PMID: 27904554
PMC: 5121998.
DOI: 10.4103/1735-1995.177355.
Role of Helicobacter pylori infection on nutrition and metabolism.
Franceschi F, Annalisa T, Teresa D, Giovanna D, Ianiro G, Franco S
World J Gastroenterol. 2014; 20(36):12809-17.
PMID: 25278679
PMC: 4177464.
DOI: 10.3748/wjg.v20.i36.12809.
The Role of Helicobacter pylori Seropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance.
Malamug L, Karnchanasorn R, Samoa R, Chiu K
Scientifica (Cairo). 2014; 2014:870165.
PMID: 24790772
PMC: 3984821.
DOI: 10.1155/2014/870165.
The Eradication of Helicobacter pylori does not Affect Glycemic Control in Japanese Subjects with Type 2 Diabetes.
Wada Y, Hamamoto Y, Kawasaki Y, Honjo S, Fujimoto K, Tatsuoka H
Jpn Clin Med. 2013; 4:41-3.
PMID: 23966817
PMC: 3742360.
DOI: 10.4137/JCM.S10828.
The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies.
Pfeiffer M, von Bauer R, Nawroth P
Langenbecks Arch Surg. 2011; 396(7):941-7.
PMID: 21448725
DOI: 10.1007/s00423-011-0781-z.
Helicobacter pylori and insulin resistance: time to do interventional studies.
Pellicano R, Rizzetto M
Dig Dis Sci. 2009; 54(12):2765-6.
PMID: 19789977
DOI: 10.1007/s10620-009-0972-4.
